![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de categorías
AlcoholismoAlzheimer Y ParkinsonAnalgésicosAntialérgicasAntibióticosAnticonceptivosAnticonvulsivosAntidepresivosAntifúngicosAntiinflamatoriosAntiparasitariosAntiviralesArtritisAsmaCirugÃaColesterolCuidados De La PielCuidados De Los OjosCáncerDiabetesDisfunción EréctilDiuréticosEnfermedad CardiovascularEnfermedades GastrointestinalesEnfermedades GenitourinariasEnfermedades NeurológicasMedicamentos V I HMigrañasOsteoporosisPresión ArterialPérdida De PesoRelajantes MuscularesSalud FemeninaSalud MasculinaTracto RespiratorioTrastornos Mentales 16 May 2012 11:15:59
Hyman, Phelps, & McNamara, PC | Decisions, Decisions, Decisions! Our Updated ...Hyman, Phelps, & McNamara, PC Decisions, Decisions, Decisions! Our Updated ... Linex Legal (press release) (registration) FDA-2009-P-0411 â ACTOS (pioglitazone HCl) & ACTOPLUS MET (March 15, 2010) (pioglitazone HCl; metformin HCl) FDA Response, Docket No. FDA-2009-P-0601 (June 17, 2010) â NAROPIN (ropivacaine HCl monohydrate) FDA Response, Docket No.
02 May 2012 14:06:27
Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced ...Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced ... MarketWatch (press release) ... Canagliflozin 1096.4.9 MB07803 1107 Diabetes Therapeutics Market to 2017 - Competitive Landscape 1117.1 Diabetes Market Overview 1117.1.1 Human Insulin Products and Oral Antidiabetic Drugs like Actos Group (Actos and Actoplus Met ) and Lantus Have ...
27 Apr 2012 12:04:41
Research and Markets: Type 2 Diabetes - Global Drug Forecasts and Treatment ...Research and Markets: Type 2 Diabetes - Global Drug Forecasts and Treatment ... SunHerald.com The annual cost of therapy was also driven by the increased use of multiple drugs per patient and the adoption of combination therapies, such as Actoplusmet (pioglitazone and metformin), Avandamet (rosiglitazone and metformin), Janumet (sitagliptin and ...
25 Apr 2012 15:16:27
New Market Study: "Type 2 Diabetes - Global Drug Forecasts and Treatment ...New Market Study: "Type 2 Diabetes - Global Drug Forecasts and Treatment ... SBWire (press release) The annual cost of therapy was also driven by the increased use of multiple drugs per patient and the adoption of combination therapies, such as Actoplusmet (pioglitazone and metformin), Avandamet (rosiglitazone and metformin), Janumet (sitagliptin and ...
|
|
Choose Your language:
Site search
Testimonios de nuestros clientes
Recibà el encargo muy rápido. Verdaderamente era impressoné por la velocidad de entrega. - Mike
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|Nuestra polÃtica|F.A.Q.|Testimonios de nuestros clientes|Contacto|Sitemap |
|
|
|
|
| |